Product Code: SR112024A4374
The global airway management devices market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.
Airway management devices are utilized for maintaining or restoring ventilation in a patient. It also involves evaluating, planning, and using different medical procedures to treat patients with respiratory failures or acute obstruction. Besides this, it protects the lungs from injury and provides gas exchange facilities to the patients. Some of the commonly used airway management devices to keep the upper airway open for offering unobstructed ventilation are supraglottic airway devices (SADs), tracheal intubation, transtracheal access, airway clearance.
Airway Management Devices Market Trends:
The increasing prevalence of respiratory diseases represents one of the key factors driving the market. Additionally, on account of the growing number of surgeries, there is a rise in the utilization of anesthesia. This, in confluence with numerous benefits of airway management devices, such as the high efficiency in airway clearance and maintenance of proper ventilation and patient safety during operative procedures, is also contributing to the market growth. Besides this, an increase in the emergency treatment of prolonged illness and protracted treatment associated with lung diseases in children and adults is catalyzing the demand for airway management devices. Furthermore, the advent of advanced techniques for preoperative airway evaluation is also strengthening the market growth. For instance, Preoperative Endoscopic Airway Evaluation (PEAE) is a technique that identifies, predicts the blocked ventilation, and facilitates a plan for efficient management, which particularly involves the usage of advanced devices, such as supraglottic airway. These airway devices provide easy tracheal placement resulting in improved patient safety, and are subsequently utilized in a range of clinical applications.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global airway management devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, patient type, application and end use.
Breakup by Product:
Supraglottic Devices
Oropharyngeal Devices
Naspharyngeal Devices
Laryngeal Airway Devices
Others
Infraglottic Devices
Endotracheal Tubes
Tracheostomy Tubes
Others
Resuscitators
Laryngoscopes
Others
Breakup by Patient Type:
Adult
Pediatric Patient/Neonates
Breakup by Application:
Anesthesia
Emergency Medicine
Others
Breakup by End Use:
Hospitals
Homecare
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ambu A/S, Armstrong Medical Ltd., Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd., Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH and Verathon Inc. (Roper Technologies Inc.).
Key Questions Answered in This Report
- 1. What is the expected growth rate of the global airway management devices market during 2024-2032?
- 2. What are the key factors driving the global airway management devices market?
- 3. What has been the impact of COVID-19 on the global airway management devices market?
- 4. What is the breakup of the global airway management devices market based on the product?
- 5. What is the breakup of the global airway management devices market based on the patient type?
- 6. What is the breakup of the global airway management devices market based on the application?
- 7. What is the breakup of the global airway management devices market based on the end use?
- 8. What are the key regions in the global airway management devices market?
- 9. Who are the key players/companies in the global airway management devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Airway Management Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Supraglottic Devices
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Oropharyngeal Devices
- 6.1.2.2 Naspharyngeal Devices
- 6.1.2.3 Laryngeal Airway Devices
- 6.1.2.4 Others
- 6.1.3 Market Forecast
- 6.2 Infraglottic Devices
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Endotracheal Tubes
- 6.2.2.2 Tracheostomy Tubes
- 6.2.2.3 Others
- 6.2.3 Market Forecast
- 6.3 Resuscitators
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Laryngoscopes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Patient Type
- 7.1 Adult
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Pediatric Patient/Neonates
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Anesthesia
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Emergency Medicine
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End Use
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Homecare
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Ambu A/S
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Armstrong Medical Ltd.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Becton Dickinson and Company
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Flexicare (Group) Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Intersurgical Ltd.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 SWOT Analysis
- 15.3.6 Medline Industries Inc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 Medtronic plc
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Mercury Enterprises Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Smiths Group plc
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Teleflex Incorporated
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 VBM Medizintechnik GmbH
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 Verathon Inc. (Roper Technologies Inc.)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 SWOT Analysis